Esperion Therapeutics Inc. (NASDAQ:ESPR) has a beta value of 0.88 and has seen 4.19 million shares traded in the last trading session. The company, currently valued at $323.80M, closed the last trade at $1.90 per share which meant it lost -$0.09 on the day or -4.52% during that session. The ESPR stock price is -78.95% off its 52-week high price of $3.40 and 63.16% above the 52-week low of $0.70. The 3-month trading volume is 6.25 million shares.

Esperion Therapeutics Inc. (NASDAQ:ESPR) trade information

Sporting -4.52% in the red in last session, the stock has traded in the red over the last five days, when the ESPR stock price touched $1.90 or saw a rise of 12.04%. Year-to-date, Esperion Therapeutics Inc. shares have moved -36.45%, while the 5-day performance has seen it change -2.56%. Over the past 30 days, the shares of Esperion Therapeutics Inc. (NASDAQ:ESPR) have changed -27.48%.

Esperion Therapeutics Inc. (ESPR) estimates and forecasts

Figures show that Esperion Therapeutics Inc. shares have outperformed across the wider relevant industry. The company’s shares have gained 149.15% over the past 6 months, with this year growth rate of 66.50%, compared to 10.50% for the industry.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 23.09% over the past 5 years. Earnings growth for 2024 is a modest 80.92% while over the next 5 years, the company’s earnings are expected to increase by 16.90%.

ESPR Dividends

Esperion Therapeutics Inc. is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.